Drugs News and Research

RSS

Scientists find that DNA repair drug could help treat leukaemia, other cancers

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore at the National University of Singapore found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

Insight could lead to new and better drugs

There's a certain type of biomolecule built like a nano-Christmas tree. Called a glycoconjugate, it's many branches are bedecked with sugary ornaments.

26 Aug 2014

Sorrento receives funding to advance immunotherapy targeting WISP1 for treatment of IPF

Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that it has received funding to advance an immunotherapy targeting WNT1-Inducible Signaling Protein-1 (WISP1) for the potential treatment of IPF, which affects more than 100,000 Americans.

26 Aug 2014

First Edition: August 26, 2014

Today's early morning highlights from major news organizations, including a report about how what some say is a health law "drafting error" and other's term a "political miscalculation" could become the measure's trouble spot.

26 Aug 2014

State highlights: Calif. hospital accused of patient dumping; Wash. mental health changes

Los Angeles City Atty. Mike Feuer has filed a lawsuit accusing Glendale Adventist Medical Center of dumping mentally ill and disabled homeless patients on L.A.'s skid row over the last four years. The six-page complaint, filed Wednesday in Los Angeles County Superior Court, said the hospital improperly transported elderly and dependent patients to the downtown Los Angeles neighborhood, a 50-block area "known for extreme poverty, homelessness, rampant sale and use of illegal drugs and violent crime" (Holland, 8/22).

26 Aug 2014

Scientists pave way for improved tools to predict and monitor cancer

Scientists have shown how to better identify and measure vital molecules that control cell behaviour - paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

From The University of Manchester 26 Aug 2014

Some nonprofits opposing contraceptive coverage appear unswayed by new rule

Catholic bishops and other conservative groups suggest the accommodations do not satisfy their concerns.

26 Aug 2014

Authors emphasize benefits of calcium and vitamin D supplements on bone health

Calcium and vitamin D are essential to keeping bones strong, dense and healthy as we age, as well as preventing bone loss, osteporosis, and skeletal fractures.

26 Aug 2014

Viewpoints: Spreading Ebola treatments; Dems can win running on health law

A radical but promising proposal to help treat victims of the Ebola epidemic in West Africa appears to be gaining support among knowledgeable experts.

26 Aug 2014

Research delves into social norms and beliefs of teenage male electronic cigarette users

"The Social Norms and Beliefs of Teenage Male Electronic Cigarette Use," a research study published in Journal of Ethnicity in Substance Abuse (Routledge), delves into the social norms and beliefs of teenage male electronic cigarette users.

26 Aug 2014

Scientists identify number of compounds to treat cancer could add to anti-malarial arsenal

Scientists searching for new drugs to fight malaria have identified a number of compounds -- some of which are currently in clinical trials to treat cancer -- that could add to the anti-malarial arsenal.

26 Aug 2014

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Acromegaly is a chronic, life-threatening disease triggered by a benign tumour of the pituitary gland causing excessive growth hormone release. Oversupply of growth hormone stimulates liver, fat and kidney cells to produce excess levels of Insulin-Like Growth Factor I (IGFI), which causes abnormal growth of the bones of the hands, face and feet and bodily organs.

26 Aug 2014

Study sheds new light on sleep drunkenness disorder

A study is shining new light on a sleep disorder called "sleep drunkenness". The disorder may be as prevalent as affecting one in every seven people. The research is published in the August 26, 2014, print issue of Neurology, the medical journal of the American Academy of Neurology.

26 Aug 2014

Researchers find why certain glioblastomas become drug resistance

Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy.

26 Aug 2014

BD announces winners of 2014 "Innovations in Care" awards

BD (Becton, Dickinson and Company), a leading global medical technology company – together with Direct Relief and the National Association of Community Health Centers – has announced the winners of the 2014 "Innovations in Care" awards to seven community health centers as part of the BD Helping Build Healthy CommunitiesSM initiative.

From BD (Becton, Dickinson and Company) 26 Aug 2014

NEOMED gets $12 million to support academic researchers on drug development

NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.

26 Aug 2014

Drugs News and Research

Scientists find that DNA repair drug could help treat leukaemia, other cancers

Insight could lead to new and better drugs

Sorrento receives funding to advance immunotherapy targeting WISP1 for treatment of IPF

First Edition: August 26, 2014

State highlights: Calif. hospital accused of patient dumping; Wash. mental health changes

Scientists pave way for improved tools to predict and monitor cancer

Some nonprofits opposing contraceptive coverage appear unswayed by new rule

Authors emphasize benefits of calcium and vitamin D supplements on bone health

Viewpoints: Spreading Ebola treatments; Dems can win running on health law

Research delves into social norms and beliefs of teenage male electronic cigarette users

Scientists identify number of compounds to treat cancer could add to anti-malarial arsenal

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

Acromegaly and antisense therapy: an interview with Mark Diamond, CEO Antisense Therapeutics

Study sheds new light on sleep drunkenness disorder

Researchers find why certain glioblastomas become drug resistance

BD announces winners of 2014 "Innovations in Care" awards

NEOMED gets $12 million to support academic researchers on drug development

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Researchers develop new integrated approach to pinpoint genetic "drivers" of cancer

Researchers find more selective therapies for cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News